Search Results - "Peligros, María Isabel"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing by Prieto-García, Alicia, Peligros, María Isabel, Pérez Tamayo, Isabel, Zubeldia, José Manuel, Álvarez-Sala, Luis, Lavilla, Cristina

    Published in The Journal of asthma (2024)
    “…Mepolizumab, a humanized anti IL-5 monoclonal antibody, has been used off-label for chronic eosinophilic pneumonia (CEP), inducing disease remission and saving…”
    Get full text
    Journal Article
  3. 3

    Post-Chemoradiation Metastatic, Persistent and Resistant Nodes in Locally Advanced Rectal Cancer: Metrics and Their Impact on Long-Term Outcome by Calvo, Felipe A, Tudela, María, Serrano, Javier, Muñoz-Fernández, Mercedes, Peligros, María Isabel, Garcia-Alfonso, Pilar, del Valle, Emilio

    Published in Cancers (01-09-2023)
    “…Background: The purpose of this study was to evaluate the long-term oncological progression pattern of locally advanced rectal cancer patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing by Prieto-García, Alicia, Peligros, María Isabel, Pérez Tamayo, Isabel, Zubeldia, José Manuel, Álvarez-Sala, Luis, Lavilla, Cristina

    Published in Journal of Asthma (19-07-2023)
    “…Mepolizumab, a humanized anti IL-5 monoclonal antibody, has been used off-label for chronic eosinophilic pneumonia (CEP), inducing disease remission and saving…”
    Get full text
    Report
  13. 13
  14. 14
  15. 15